Dokuz Eylül University

Running trials

• Recruiting

  Speech-based Assessment of Relapse Risk in People With Psychosis

  NCT07397975· Source

• Active, not recruiting

  The Effect of Acceptance and Commitment Approach-Based Psychoeducation in Cancer Survivors

  NCT07205965· Source

• Not yet recruiting

  Can Neoadjuvant Chemoradiotherapy be Ommited in Mid-rectal Cancer

  NCT06823297· Source

• Recruiting

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· Phase 3· Source

• Not yet recruiting

  Endoscopic Submucosal Dissection vs. Transanal Endoscopic Surgery for Rectal Neoplasia

  NCT06902701· Source

• Recruiting

  Comparison of Two-Position and Four-Position Cervical Injection Techniques for Sentinel Lymph Node Mapping in Endometrial Cancer Using Methylene Blue

  NCT07040657· Source

• Recruiting

  A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

  NCT06846671· Phase 3· Source

• Recruiting

  FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

  NCT06788990· Phase 2/3· Source

• Active, not recruiting

  Online Diabetic Foot Support Program- Care Kit

  NCT06760416· Source

• Active, not recruiting

  Hypoglycemia Prevention and Awareness Program

  NCT06775288· Source

• Recruiting

  Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

  NCT06463587· Phase 3· Source

• Enrolling by invitation

  Structured Follow-up Intervention on Glucose Status After Pancreatic Cancer Surgery

  NCT06774170· Source

• Recruiting

  A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

  NCT06149286· Phase 3· Source

• Recruiting

  A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

  NCT06091865· Phase 3· Source

• Active, not recruiting

  A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

  NCT05556512· Phase 3· Source

• Active, not recruiting

  A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers

  NCT05152147· Phase 3· Source

• Recruiting

  A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

  NCT05006716· Phase 1/2· Source

• Active, not recruiting

  Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

  NCT04666038· Phase 3· Source

• Active, not recruiting

  A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

  NCT04232553· Phase 3· Source

• Active, not recruiting

  Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease

  NCT04166565· Phase 2· Source

• Active, not recruiting

  Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)

  NCT03711032· Phase 3· Source

• Active, not recruiting

  Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.

  NCT03229200· Phase 4· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic lymphocytic leukaemia2 recruiting
• Colorectal cancer2 recruiting
• Diffuse large B-cell lymphoma2 recruiting
• Follicular lymphoma2 recruiting
• Childhood cancers1 recruiting
• Endometrial cancer1 recruiting
• Head and neck cancer1 recruiting
• High blood pressure1 recruiting
• Mantle cell lymphoma1 recruiting
• Myasthenia gravis1 recruiting
• Pancreatic cancer1 recruiting
• Schizophrenia1 recruiting
• Type 2 diabetes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  The Effect of a ChatGPT-Supported Online Group-Guided Self-Help Program on Uncontrolled and Emotional Eating Behaviors and Body Image in Overweight and Obese Woman Nurses

  NCT06653673· Source

• Completed

  Reliability of BASDAI and BASFI Applied by Tele-Assessment Method in Axial SpA Spondyloarthritis

  NCT06230952· Source

• Completed

  Online Diabetes Clinic Support Program

  NCT06767865· Source

• Completed

  Acute Responses of Active Video Games and Traditional Exercise Program in in Patients With Pulmonary Hypertension

  NCT05901168· Source

• Completed

  Early-phase Exercise-based Cardiac Rehabilitation After MI

  NCT06924034· Source

• Completed

  Lifestyle Change in Women With Polycystic Ovary Syndrome

  NCT05377021· Source

• Completed

  Investigation of the Effects of Family-Focused Therapy in the Early Period of Bipolar Disorder and Psychotic Disorder

  NCT05809193· Source

• Completed

  Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11)

  NCT05008224· Phase 2· Source

• Completed

  Yoga and Aerobic Exercise in Epilepsy

  NCT05066880· Source

• Terminated

  To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)

  NCT04551066· Phase 3· Source

• Completed

  A Study of the Efficacy and Safety of Frespaciguat (MK-5475) in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007)

  NCT04732221· Phase 2/3· Source

• Completed

  A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

  NCT04255433· Phase 3· Source

• Completed

  Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)

  NCT03867084· Phase 3· Source

Trial sites

• Dokuz Eylül Üniversitesi3 trials
• Dokuz Eylül Üniversitesi (Site 5002)1 trial
• Dokuz Eylul University3 trials
• Dokuz Eylul Universitesi1 trial
• Dokuz Eylul Universitesi (Site 0740)1 trial
• Dokuz Eylul Universitesi (Site 0959)1 trial
• Dokuz Eylul University19 trials
• Dokuz Eylul University Faculty of Medicine2 trials
• Dokuz Eylul University Faculty of Medicine - Neurology Department1 trial
• Dokuz Eylul University Faculty of Medicine (Site 0505)1 trial
• Dokuz Eylül University Faculty of Nursing1 trial
• Dokuz Eylul University Medical School (Site # 1206)1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Bipolar disorder25 works · 1 trials
• Ankylosing spondylitis12 works · 1 trials
• Neuroblastoma10 works · 0 trials
• Hepatitis B9 works · 0 trials
• Lewy body dementia4 works · 0 trials